These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 1692469)
1. C595--a monoclonal antibody against the protein core of human urinary epithelial mucin commonly expressed in breast carcinomas. Price MR; Pugh JA; Hudecz F; Griffiths W; Jacobs E; Symonds IM; Clarke AJ; Chan WC; Baldwin RW Br J Cancer; 1990 May; 61(5):681-6. PubMed ID: 1692469 [TBL] [Abstract][Full Text] [Related]
2. Development of an anti-idiotypic antibody reactive with an antibody defining the epitope RPAP in the MUC-1 epithelial mucin core. Bashford JL; Robins RA; Price MR Int J Cancer; 1993 Jul; 54(5):778-83. PubMed ID: 7686886 [TBL] [Abstract][Full Text] [Related]
3. Immunological and structural features of the protein core of human polymorphic epithelial mucin. Price MR; Hudecz F; O'Sullivan C; Baldwin RW; Edwards PM; Tendler SJ Mol Immunol; 1990 Aug; 27(8):795-802. PubMed ID: 1698259 [TBL] [Abstract][Full Text] [Related]
4. Multiple epitopes on a human breast-carcinoma-associated antigen. Price MR; Edwards S; Owainati A; Bullock JE; Ferry B; Robins RA; Baldwin RW Int J Cancer; 1985 Nov; 36(5):567-74. PubMed ID: 2414233 [TBL] [Abstract][Full Text] [Related]
5. Purification of anti-epithelial mucin monoclonal antibodies by epitope affinity chromatography. Price MR; Sekowski M; Tendler SJ J Immunol Methods; 1991 May; 139(1):83-90. PubMed ID: 1710253 [TBL] [Abstract][Full Text] [Related]
6. Epitope analysis of monoclonal antibody NCRC-11 defined antigen isolated from human ovarian and breast carcinomas. Price MR; Edwards S; Powell M; Baldwin RW Br J Cancer; 1986 Sep; 54(3):393-400. PubMed ID: 2428391 [TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies reactive with the breast carcinoma-associated mucin core protein repeat sequence peptide also recognise the ovarian carcinoma-associated sebaceous gland antigen. Layton GT; Devine PL; Warren JA; Birrell G; Xing PX; Ward BG; McKenzie IF Tumour Biol; 1990; 11(5):274-86. PubMed ID: 1697426 [TBL] [Abstract][Full Text] [Related]
8. The mucin antigens: what are we measuring? Price MR; Briggs S; Scanlon MJ; Tendler SJ; Sibley PE; Hand CW Dis Markers; 1991; 9(3-4):205-12. PubMed ID: 1725974 [TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies reactive with mucin expressed in breast cancer. Xing PX; Tjandra JJ; Stacker SA; Teh JG; Thompson CH; McLaughlin PJ; McKenzie IF Immunol Cell Biol; 1989 Jun; 67 ( Pt 3)():183-95. PubMed ID: 2477330 [TBL] [Abstract][Full Text] [Related]
10. Characterization of new pancreatic cancer-reactive monoclonal antibodies directed against purified mucin. Ho JJ; Bi N; Yan PS; Yuan M; Norton KA; Kim YS Cancer Res; 1991 Jan; 51(1):372-80. PubMed ID: 1703039 [TBL] [Abstract][Full Text] [Related]
11. Biochemical and immunochemical analysis of a breast carcinoma associated antigen defined by the monoclonal antibody NCRC-11. Price MR Arch Geschwulstforsch; 1987; 57(3):177-80. PubMed ID: 2441681 [TBL] [Abstract][Full Text] [Related]
12. Fine specificity of antibody recognition of carcinoma-associated epithelial mucins: antibody binding to synthetic peptide epitopes. Briggs S; Price MR; Tendler SJ Eur J Cancer; 1993; 29A(2):230-7. PubMed ID: 7678496 [TBL] [Abstract][Full Text] [Related]
13. Peptide epitope binding and fluorescence quenching with the anti-mucin antibody C595. Scanlon MJ; Price MR; Tendler SJ Cancer Lett; 1992 Apr; 63(3):199-202. PubMed ID: 1374287 [TBL] [Abstract][Full Text] [Related]
14. Effect of modification of carbohydrate side chains on the reactivity of antibodies with core-protein epitopes of the MUC1 gene product. Burchell J; Taylor-Papadimitriou J Epithelial Cell Biol; 1993 Oct; 2(4):155-62. PubMed ID: 7505698 [TBL] [Abstract][Full Text] [Related]
15. Expression of monoclonal-antibody-defined antigens in fractions isolated from human breast carcinomas and patients' serum. Croce MV; Price MR; Segal-Eiras A Cancer Immunol Immunother; 1995 Feb; 40(2):132-7. PubMed ID: 7882384 [TBL] [Abstract][Full Text] [Related]
16. Detection of polymorphic epithelial mucins in the serum of systemic breast cancer patients using the monoclonal antibody, NCRC-11. Price MR; Clarke AJ; Robertson JF; O'Sullivan C; Baldwin RW; Blamey RW Cancer Immunol Immunother; 1990; 31(5):269-72. PubMed ID: 2376045 [TBL] [Abstract][Full Text] [Related]
17. Anti-colorectal carcinoma monoclonal antibodies reactive with human milk fat globular membranes. Teh JG; Xing PX; McKenzie IF Immunol Cell Biol; 1990 Jun; 68 ( Pt 3)():207-16. PubMed ID: 1699885 [TBL] [Abstract][Full Text] [Related]
18. Second generation anti-MUC1 peptide monoclonal antibodies. Xing PX; Prenzoska J; Quelch K; McKenzie IF Cancer Res; 1992 Apr; 52(8):2310-7. PubMed ID: 1373108 [TBL] [Abstract][Full Text] [Related]
19. Purification and biochemical characterisation of a novel breast carcinoma associated mucin-like glycoprotein defined by antibody 3E1.2. Stacker SA; Tjandra JJ; Xing PX; Walker ID; Thompson CH; McKenzie IF Br J Cancer; 1989 Apr; 59(4):544-53. PubMed ID: 2469454 [TBL] [Abstract][Full Text] [Related]
20. Polymorphic epithelial mucin from the sera of advanced breast cancer patients--isolation and partial characterisation. O'Sullivan C; Price MR; Baldwin RW Br J Cancer; 1990 Jun; 61(6):801-8. PubMed ID: 1695521 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]